KUX-1151
/ Kissei, Pfizer
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 20, 2015
Phase II Exploratory Clinical Study of KUX-1151
(clinicaltrials.gov)
- P2; N=N/A; Completed; Sponsor: Kissei Pharmaceutical Co., Ltd.; Active, not recruiting ➔ Completed
Trial completion • Biosimilar
1 to 1
Of
1
Go to page
1